Ricardo J. Estrada-Mendizabal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ricardo J. Estrada-Mendizabal has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Alejandra Canel-Paredes
Division of Allergy and Clinical Immunology, Hospital Zambrano-Hellion, Monterrey, N.L., Mexico
3 shared publications Alejandro Recio-Boiles
Department of Medicine, University of Arizona College of Medicine, Tucson, AZ; Department of Hematology/Oncology, University of Arizona Cancer Center, Tucson, AZ
3 shared publications- Alexei Gonzalez-Estrada
Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA
3 shared publications - Juan Chipollini
The University of Arizona
3 shared publications Alexei Gonzalez-Estrada
Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, Scottsdale, Ariz
2 shared publicationsCarlos De la Cruz-De la Cruz
Internal Medicine Department, Universidad de Monterrey, Monterrey, NL, Mexico
2 shared publications
Latest Publications
- 3 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (21)
Disparities in Editorial Leadership of Highly Cited Cardiology Journals by Gender and Country Income Classification
- 3 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (21)
Disparities in Editorial Leadership of Highly Cited Cardiology Journals by Gender and Country Income Classification
- Open Access
- 25 October 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (10) , e70707
Molecular and Immune Features of Metastatic Prostate Cancer in Hispanic and Non‐Hispanic American Men
Background: Prostate cancer (PCa) is the most common solid tumor in American men, with persistent ethnic disparities, particularly among Hispanic American (HA) men. The tumor microenvironment (TME) and tumor genomics may contribute to disease progression but remain undercharacterized in HA populations. Methods: We conducted a retrospective exploratory analysis of 83 patients with treatment‐naïve metastatic hormone‐sensitive prostate cancer who underwent next‐generation sequencing (NGS). Tumor genomic alterations, immune profiles, pathway activity, and clinical characteristics were compared between HA and non‐Hispanic White (NHW) patients. Results: Compared with NHW patients, HA patients presented with higher PSA levels (111.5 vs. 52.6 ng/mL, p = 0.02), and more advanced disease, including T4 tumors (41% vs. 14%, p = 0.01) and visceral metastases (41% vs. 16%, p = 0.04). Pathway analyses identified increased KRAS (FDR = 0.02), Hedgehog (FDR = 0.04), and NOTCH (FDR = 0.07) signaling in HA tumors. HA tumors exhibited higher expression of stem cell markers ( ALDH1A1 , ALDH1A2 , PROM1 ) and immunoinhibitory genes ( PDCD1LG2 , FOXP3 ) (all p < 0.05), along with increased infiltration of M1 macrophages (0.72% vs. 0%) and natural killer (NK) cells (4.84% vs. 3.55%, all p < 0.05 and q < 0.10). HA tumors demonstrated higher expression of genes associated with drug efflux ( ABCC1, ABCB1 ), EMT ( TWIST1, MMP2 ), cell cycle ( CCND2 ), apoptosis inhibition ( BIRC2, XIAP ), and epigenetic regulation ( EP300, TET1, TET2 ) (all p < 0.05 and q < 0.10). Clinically, HA patients initiated therapy earlier (1 vs. 3 months, p ≤ 0.01), had a longer interval to second‐line therapy (20 vs. 11 months, p < 0.05), and had shorter follow‐up (23 vs. 44 months, p = 0.03). Conclusions: HA patients demonstrated differences in genomic alterations, pathway activity, and tumor immune features compared with NHW patients. Given the study's modest sample size and observational design, these findings should be considered hypothesis‐generating and warrant validation in larger prospective cohorts with broader representation of Hispanic American men.
- 25 October 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (10) , e70707
Open AccessMolecular and Immune Features of Metastatic Prostate Cancer in Hispanic and Non‐Hispanic American Men
Background: Prostate cancer (PCa) is the most common solid tumor in American men, with persistent ethnic disparities, particularly among Hispanic American (HA) men. The tumor microenvironment (TME) and tumor genomics may contribute to disease progression but remain undercharacterized in HA populations. Methods: We conducted a retrospective exploratory analysis of 83 patients with treatment‐naïve metastatic hormone‐sensitive prostate cancer who underwent next‐generation sequencing (NGS). Tumor genomic alterations, immune profiles, pathway activity, and clinical characteristics were compared between HA and non‐Hispanic White (NHW) patients. Results: Compared with NHW patients, HA patients presented with higher PSA levels (111.5 vs. 52.6 ng/mL, p = 0.02), and more advanced disease, including T4 tumors (41% vs. 14%, p = 0.01) and visceral metastases (41% vs. 16%, p = 0.04). Pathway analyses identified increased KRAS (FDR = 0.02), Hedgehog (FDR = 0.04), and NOTCH (FDR = 0.07) signaling in HA tumors. HA tumors exhibited higher expression of stem cell markers ( ALDH1A1 , ALDH1A2 , PROM1 ) and immunoinhibitory genes ( PDCD1LG2 , FOXP3 ) (all p < 0.05), along with increased infiltration of M1 macrophages (0.72% vs. 0%) and natural killer (NK) cells (4.84% vs. 3.55%, all p < 0.05 and q < 0.10). HA tumors demonstrated higher expression of genes associated with drug efflux ( ABCC1, ABCB1 ), EMT ( TWIST1, MMP2 ), cell cycle ( CCND2 ), apoptosis inhibition ( BIRC2, XIAP ), and epigenetic regulation ( EP300, TET1, TET2 ) (all p < 0.05 and q < 0.10). Clinically, HA patients initiated therapy earlier (1 vs. 3 months, p ≤ 0.01), had a longer interval to second‐line therapy (20 vs. 11 months, p < 0.05), and had shorter follow‐up (23 vs. 44 months, p = 0.03). Conclusions: HA patients demonstrated differences in genomic alterations, pathway activity, and tumor immune features compared with NHW patients. Given the study's modest sample size and observational design, these findings should be considered hypothesis‐generating and warrant validation in larger prospective cohorts with broader representation of Hispanic American men.
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (4) , e014692
Post-Catheter Ablation Long-Term Antithrombotic Strategies in Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Catheter ablation for atrial fibrillation is a widely used rhythm-control strategy, yet its role in reducing thromboembolic risk and enabling oral anticoagulation (OAC) discontinuation remains uncertain. This meta-analysis aims to comprehensively synthesize and evaluate randomized controlled trial evidence supporting long-term antithrombotic strategies in patients with atrial fibrillation undergoing catheter ablation. METHODS: A systematic literature search was performed in MEDLINE/PubMed, Embase, and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials evaluating antithrombotic strategies after catheter ablation for atrial fibrillation. The primary outcome was ischemic stroke. A frequentist network meta-analysis comparing reported treatment arms, along with a pooled incidence meta-analysis for outcomes of interest, was conducted. RESULTS: Four randomized controlled trials, including 3924 patients, met the inclusion criteria. Three trials compared long-term OAC continuation versus OAC discontinuation, and 1 compared OAC continuation with left atrial appendage occlusion after catheter ablation. No significant differences in stroke incidence were observed when comparing OAC or left atrial appendage occlusion with no antithrombotic therapy (incidence rate ratio, 0.90 [95% CI, 0.02–33.85]; P =0.95; incidence rate ratio, 0.79 [95% CI, 0.00–241.01]; P =0.94, respectively). Among patients who discontinued antithrombotic therapy without undergoing left atrial appendage occlusion (n=1161), with 2864 cumulative person-years of follow-up, the pooled incidence of stroke was 0.23 events per 100 person-years (95% CI, 0.02–2.43; I 2 =0%). CONCLUSIONS: This analysis reinforces that, across randomized data, the incidence of thromboembolic events in patients who discontinued OAC after successful ablation remained low. However, the evaluation of net clinical benefit is limited by the low number of events across all treatment arms, underscoring the need for larger studies with prolonged follow-up to further validate the safety of this strategy, particularly in higher-risk populations.
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (4) , e014692
Open AccessPost-Catheter Ablation Long-Term Antithrombotic Strategies in Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Catheter ablation for atrial fibrillation is a widely used rhythm-control strategy, yet its role in reducing thromboembolic risk and enabling oral anticoagulation (OAC) discontinuation remains uncertain. This meta-analysis aims to comprehensively synthesize and evaluate randomized controlled trial evidence supporting long-term antithrombotic strategies in patients with atrial fibrillation undergoing catheter ablation. METHODS: A systematic literature search was performed in MEDLINE/PubMed, Embase, and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials evaluating antithrombotic strategies after catheter ablation for atrial fibrillation. The primary outcome was ischemic stroke. A frequentist network meta-analysis comparing reported treatment arms, along with a pooled incidence meta-analysis for outcomes of interest, was conducted. RESULTS: Four randomized controlled trials, including 3924 patients, met the inclusion criteria. Three trials compared long-term OAC continuation versus OAC discontinuation, and 1 compared OAC continuation with left atrial appendage occlusion after catheter ablation. No significant differences in stroke incidence were observed when comparing OAC or left atrial appendage occlusion with no antithrombotic therapy (incidence rate ratio, 0.90 [95% CI, 0.02–33.85]; P =0.95; incidence rate ratio, 0.79 [95% CI, 0.00–241.01]; P =0.94, respectively). Among patients who discontinued antithrombotic therapy without undergoing left atrial appendage occlusion (n=1161), with 2864 cumulative person-years of follow-up, the pooled incidence of stroke was 0.23 events per 100 person-years (95% CI, 0.02–2.43; I 2 =0%). CONCLUSIONS: This analysis reinforces that, across randomized data, the incidence of thromboembolic events in patients who discontinued OAC after successful ablation remained low. However, the evaluation of net clinical benefit is limited by the low number of events across all treatment arms, underscoring the need for larger studies with prolonged follow-up to further validate the safety of this strategy, particularly in higher-risk populations.
- 24 October 2025
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (2) , 195-203.e4
Sex-based differences in perioperative hypersensitivity
- 24 October 2025
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (2) , 195-203.e4
Sex-based differences in perioperative hypersensitivity
- 6 May 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (5) , 1241-1242
Reply to “Correspondence regarding ‘Assessing the accuracy of ChatGPT’s responses to common allergy myths’”
- 6 May 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (5) , 1241-1242
Reply to “Correspondence regarding ‘Assessing the accuracy of ChatGPT’s responses to common allergy myths’”
- 14 April 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (8) , 2204-2205
Gender and geographically based disparities among editors and editorial board members in highly cited allergy journals
- 14 April 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (8) , 2204-2205
Gender and geographically based disparities among editors and editorial board members in highly cited allergy journals
- 1 March 2025
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (5) , 337.e1-337.e8
A retrospective analysis of tissue, liquid, and germline testing in Hispanic and non-Hispanic men with advanced hormone-sensitive prostate cancer
- 1 March 2025
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (5) , 337.e1-337.e8
A retrospective analysis of tissue, liquid, and germline testing in Hispanic and non-Hispanic men with advanced hormone-sensitive prostate cancer
- Open Access
- 4 February 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e001101
Impact of the COVID-19 pandemic on the volume and diagnoses of patients admitted to the paediatric emergency department: a retrospective analysis from a third-level hospital in Northeastern Mexico
Background: During the COVID-19 pandemic, there were noticeable changes in the number of admissions to paediatric emergency departments (EDs) worldwide, as well as in the patient’s diagnoses. There is scarce evidence about the impact of the pandemic on paediatric EDs in Latin America and Mexico. This study aimed to analyse the changes in volume and discharge diagnoses of patients admitted to a third-level paediatric ED in northeastern Mexico before and during the COVID-19 pandemic. Methods: A retrospective observational study was carried out to compare the number of admissions and discharge diagnoses between two 3-month periods: December 2020–February 2021 (prepandemic) and December 2019–February 2020 (pandemic). Other variables, such as age, sex and comorbidities, were analysed. χ2 and Mann-Whitney U tests were used depending on the examined variable. Results: There was a 44.1% decrease in the total volume of patients admitted to the paediatric ED during the analysed pandemic period. The percentage of infectious diseases decreased from 45.7% to 19.3% (p<0.001), and respiratory diseases from 4.3% to 1.9% (p<0.001), including asthma exacerbations (3.1%–1.5%, p=0.012). There was an increase in the percentage of patients admitted due to accidents (6.6%–14.7%, p<0.001). Conclusions: A significant decrease in the total volume of patients, especially those who were admitted due to infectious and respiratory diseases, was documented. Gaining deeper knowledge of the impact of global health emergencies on the use of healthcare services is crucial for an adequate planning of resource allocation in case of future pandemics.
- 4 February 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e001101
Open AccessImpact of the COVID-19 pandemic on the volume and diagnoses of patients admitted to the paediatric emergency department: a retrospective analysis from a third-level hospital in Northeastern Mexico
Background: During the COVID-19 pandemic, there were noticeable changes in the number of admissions to paediatric emergency departments (EDs) worldwide, as well as in the patient’s diagnoses. There is scarce evidence about the impact of the pandemic on paediatric EDs in Latin America and Mexico. This study aimed to analyse the changes in volume and discharge diagnoses of patients admitted to a third-level paediatric ED in northeastern Mexico before and during the COVID-19 pandemic. Methods: A retrospective observational study was carried out to compare the number of admissions and discharge diagnoses between two 3-month periods: December 2020–February 2021 (prepandemic) and December 2019–February 2020 (pandemic). Other variables, such as age, sex and comorbidities, were analysed. χ2 and Mann-Whitney U tests were used depending on the examined variable. Results: There was a 44.1% decrease in the total volume of patients admitted to the paediatric ED during the analysed pandemic period. The percentage of infectious diseases decreased from 45.7% to 19.3% (p<0.001), and respiratory diseases from 4.3% to 1.9% (p<0.001), including asthma exacerbations (3.1%–1.5%, p=0.012). There was an increase in the percentage of patients admitted due to accidents (6.6%–14.7%, p<0.001). Conclusions: A significant decrease in the total volume of patients, especially those who were admitted due to infectious and respiratory diseases, was documented. Gaining deeper knowledge of the impact of global health emergencies on the use of healthcare services is crucial for an adequate planning of resource allocation in case of future pandemics.